Sickle cell disease trials recruiting in Massachusetts

All Sickle cell disease trials nationally

Cities in Massachusetts

Recruiting trials in Massachusetts

• A Long-term Follow-up Study in Patients Who Received BEAM-101
  NCT07373639 · Phase: Not specified · Ages: 14 Years to 37 Years · Sex: All (male and female) · Massachusetts: Boston
• A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
  NCT06546670 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 55 Years · Sex: All (male and female) · Massachusetts: Boston
• A Pilot Study on Neuroimaging in SCD: Part of The Boston Consortium to Cure Sickle Cell Disease
  NCT04166526 · Phase: Not specified · Ages: 8 Years to 18 Years · Sex: All (male and female) · Massachusetts: Boston
• A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
  NCT06609226 · Phase: Phase 3 · Ages: 2 Years and older · Sex: All (male and female) · Massachusetts: Boston
• A Study to Evaluate BMS-986470 in Healthy Volunteers and Participants With Sickle Cell Disease
  NCT06481306 · Phase: Phase 1, Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · Massachusetts: Boston
• A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
  NCT06612268 · Phase: Phase 3 · Ages: 12 Years and older · Sex: All (male and female) · Massachusetts: Boston
• ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
  NCT04398628 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · Massachusetts: Boston
• Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
  NCT06941389 · Phase: Not specified · Ages: 3 Years to 20 Years · Sex: All (male and female) · Massachusetts: Boston
• Hematopoietic Stem Cell BCL11A Enhancer Gene Editing for Severe β-Hemoglobinopathies
  NCT06647979 · Phase: Phase 1 · Ages: 13 Years to 40 Years · Sex: All (male and female) · Massachusetts: Boston
• Oral Ketamine for Treatment of Vaso-Occlusive Pain
  NCT05378555 · Phase: Phase 3 · Ages: 12 Years to 24 Years · Sex: All (male and female) · Massachusetts: Boston
• Promoting Resilience Among Adolescents and Young Adults With Sickle Cell Disease
  NCT06555939 · Phase: Not applicable (e.g. observational or device study) · Ages: 8 Years to 25 Years · Sex: All (male and female) · Massachusetts: Boston
• Study of the Role of Genetic Modifiers in Hemoglobinopathies
  NCT05799118 · Phase: Not specified · Ages: 2 Years and older · Sex: All (male and female) · Massachusetts: Boston